Soll Eye PC of NJ
Soll Eye PC of NJ was paid $434K by Medicaid between Jan 2018 and Jul 2023, across 25 billing codes. Its largest line is 92014, Ophthalmological services: medical examination and evaluation, comprehensive, established patient — 30% of everything it billed.
33Billing provider infoSOLL EYE PC OF NJ
CAMDEN, NJ 08103
CAMDEN, NJ 08103
33aNPI1821081258assigned 08/31/2005
33bProvider typeOptometrist
28Total paid$434K
24GClaims22,370
24DCodes billed25
24AFirst – last monthJan 2018 – Jul 2023
Compared with peers
Next to other Optometrist providers in New Jersey
Rank by total paid#30 of 599
Median peer was paid$2K
This provider vs. median241×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,604 | $81K | |
| 2019 | 5,603 | $102K | |
| 2020 | 4,867 | $99K | |
| 2021 | 5,225 | $151K | |
| 2022 | 990 | $26.00 | |
| 2023 | 1,081 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 30% | 8,737 | 8,713 | $128K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 17% | 4,506 | 4,494 | $75K |
| J0178 | Injection, aflibercept, 1 mg | 14% | 49 | 38 | $60K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 10% | 2,030 | 1,958 | $44K |
| 92250 | 8.9% | 1,613 | 1,607 | $39K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 5.4% | 700 | 568 | $24K |
| 92083 | 3.5% | 1,069 | 1,068 | $15K | |
| 92134 | 2.7% | 1,212 | 1,169 | $12K | |
| J9035 | Injection, bevacizumab, 10 mg | 2.0% | 220 | 183 | $9K |
| 92133 | 1.7% | 663 | 663 | $7K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1.4% | 15 | 15 | $6K |
| 92235 | 1.1% | 180 | 179 | $5K |
13 more codes
| 92225 | <1% | 220 | $3K | |
| 92020 | <1% | 251 | $3K | |
| 92136 | <1% | 116 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 38 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 13 | $540.00 |
| 92226 | <1% | 28 | $296.88 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 12 | $280.56 |
| 92201 | <1% | 50 | $252.28 | |
| 76514 | <1% | 15 | $114.62 | |
| 92015 | Determination of refractive state | 0% | 423 | $0.00 |
| S0621 | Routine ophthalmological examination including refraction; established patient | 0% | 128 | $0.00 |
| S0620 | Routine ophthalmological examination including refraction; new patient | 0% | 68 | $0.00 |
| 92283 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSOLL, SEPHEN (M.D.)